top of page
Previous Group Members
Postdoctoral Researcher
Dr. Maeva Pichon (2017-2021)
Exploring Protein Stabilisation as an Approach to Drug Discovery.
Current position: Postdoctoral Researcher at the Institut Pasteur in Paris
Doctor of Philosophy
Dr Niama Ezzaidi (2019-2023)
Lead Optimisation of Small Molecule Sulfatase Reactivators for Multiple Sulfatase Deficiency
Current position: Oxford Nanopore
Dr Laura Hayward (2019-2023)
Bio-Orthogonal Chemistry Methodologies and Chemical Biology of Cysteine Redox Signalling
Current position: Astra Zeneca
Dr Ruxandra Moraru (2019-2023)
The Use of 2-Sulfonylpyrimidines As Warheads for Targeted Covalent Inhibition
Current position: Carbosynth
Dr Robert Troup (2018-2022)
Exploring linker fluorination to optimise PROTAC potency, selectivity, and physical properties
Current position: Vertex Pharmaceuticals
Dr Michael McCoy (2017-2021)
The identification & development of novel Wnt/β-catenin signalling inhibitors
Current position: Catsi
Dr. Joseph Stephenson Clarke (2017-2021)
Exploring Protein Stabilisation as an Approach to Drug Discovery.
Current position: Evotec
Masters by Research Project
Jason Powell (2019-2020)
Optimisation of indazole derivatives to stabilise the mutant p53-Y220C and restore wild-type function. Current position: Aptuit Ltd.
Sam Alstrum-Graves (2018-2019)
Synthesis of sulfonyl pyrimidine derivatives and an investigation into their interactions with surface cysteine molecules. Current position: Avantor.
Taught Masters Project
Yichen Wei (2021-2022)
Tuncay Balkaya (2019-2020)
Fourth Year Research Project
Kai Lin (2022-2023)
Akil Jacobs (2021-2022)
Ryan McIntyre (2020-2021)
Oliver Brown (2019-2020)
Megan Jones (2019-2020)
Dominique Spicer (2018-2019)
Bradley Dickman (2018-2019)
Amelia Pullinger (2017-2018)
Phoebe Nash (2016-2017)
Third Year Research Project
Zeynep Saglam (2022-2023)
Nomagugu Moyo (2021-2022)
Danielle Holmes (2020-2021)
Marcin Mierzwa (2019-2020)
Johanna Fish (2018-2019)
Isabel Beech (2017-2018)
Rory Mulgrew (2016-2017)
bottom of page